Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nano One Materials Corp. (NANO.TO)
Burnaby, BC, CA
Nano One Materials Corp. operates as a process technology company transforming cathode active material production for lithium-ion batteries in Canada. The company offers One-PotTM, a process to produce cathode active materials for lithium-ion battery applications in electric vehicles, energy storage systems, and consumer electronics. Nano One Materials Corp. was founded in 2011 and is headquartered in Burnaby, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.00% | +1.04% | -1.02% | +2.11% | -37.01% | -9.35% | +49.23% | -65.11% | -74.94% | +79.63% | -99.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%—
-
EPS growth Chemicals - Specialty: +13.2%+61.8% ★ Q1'26: -131.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%—
-
EBIT margin Chemicals - Specialty: +8.8%—
-
ROIC Chemicals - Specialty: +5.6%-176.1% Q1'26: -141.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.8% Q1'26: +6.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-0.65× Q1'26: -0.79× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
—
est: 50.0K (-100.0%)
|
—
est: 4.39M (-100.0%)
|
18.95M
18.95M – 18.95M
+331.4% YoY
|
119.60M
119.60M – 119.60M
+531.0% YoY
|
| EBITDA |
-27.22M
|
-28.18M
|
—
— – —
|
—
— – —
|
| EBIT |
-29.04M
|
-30.15M
|
—
— – —
|
—
— – —
|
| Net Income |
-29.22M
est: -31.40M (+6.9%)
|
-11.14M
est: -27.86M (+60.0%)
|
-24.67M
-24.67M – -24.67M
+11.4% YoY
|
-29.16M
-29.16M – -29.16M
-18.2% YoY
|
| SGA |
25.35M
|
23.61M
|
—
— – —
|
—
— – —
|
| EPS |
-0.26
est: -0.28 (+7.1%)
|
-0.10
est: -0.25 (+60.0%)
|
-0.22
-0.22 – -0.22
+11.4% YoY
|
-0.26
-0.26 – -0.26
-18.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dan Blondal | Founder, Chief Executive Officer & Non Independent Director | 428.9K | male |
| Alexander Holmes | President & Chief Strategy Officer | 377.3K | male |
| Carlo Valente | Chief Financial Officer | 338.8K | male |
| Denis Geoffroy | Chief Operating Officer | 325.7K | male |
| Guoxian Liang | Senior Vice President of Technology | 258.3K | — |
| Daniel Martino | Vice President of Finance | 7.5K | male |
| Pierre Thibodeau | Senior Key Account Manager | — | — |
| Kelli Forster CHRP | Senior Vice President of People & Culture | — | female |
| Pamela Kinsman | Director of Sustainability & Corporate Affairs | — | female |
| Adam Johnson | Senior Vice President External Affairs | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NANO.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
